Quote | Nexgenrx Inc. (TSXVC:NXG:CC)
Last: | $0.35 |
---|---|
Change Percent: | 0.0% |
Open: | $0.35 |
Close: | $0.35 |
High: | $0.35 |
Low: | $0.35 |
Volume: | 17,200 |
Last Trade Date Time: | 05/06/2022 04:56:12 pm |
News | Nexgenrx Inc. (TSXVC:NXG:CC)
TORONTO, ON / ACCESSWIRE / May 17, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2024, with revenue of $4,292,731, Net Income of $460,949 and EBITDA of $770,837. The Company achieved revenue of $4,292,731 in...
TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was held on Thursday, May 16, 2024. The Meeting was held, in part, to deliver the annual financial sta...
Message Board Posts | Nexgenrx Inc. (TSXVC:NXG:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Nexgenrx Inc. Company Name:
NXG:CC Stock Symbol:
TSXVC Market:
TORONTO, ON / ACCESSWIRE / May 17, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2024, with revenue of $4,292,731, Net Income of $460,949 and EBITDA of $770,837. The Company achieved revenue of $4,292,731 in...
TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was held on Thursday, May 16, 2024. The Meeting was held, in part, to deliver the annual financial sta...
BioSyent Inc. (RX:CA) is expected to report $0.08 for Q1 2024 Heroux-Devtek Inc. (HRX:CA) is expected to report $0.31 for Q4 2024 Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD:CA) is expected to report $-0.23 for Q4 2024 Abcourt Mines Inc. (ABI:CA) is expected to report for...